How to buy Nymox Pharmaceutical Corporation stock

Nymox Pharmaceutical Corporation is a biotechnology business based in the US. Nymox Pharmaceutical Corporation shares (NYMX) are listed on the NASDAQ and all prices are listed in US Dollars.

How to buy shares in Nymox Pharmaceutical Corporation

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Nymox Pharmaceutical Corporation. Find the stock by name or ticker symbol: NYMX. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Nymox Pharmaceutical Corporation reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Nymox Pharmaceutical Corporation, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Nymox Pharmaceutical Corporation. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Our top pick for

Beginners

Robinhood

Our top pick for

Building a portfolio

Sofi Invest

Our top pick for

Advanced traders

Interactive Brokers

How we chose our top picks

We evaluate stock trading platforms against a range of metrics that include fees, ease of use, available securities and advanced tools to meet specific investor needs. We encourage you to compare stock platforms to find one that's best for your particular budget and goals.

• Our pick for beginners. We chose Robinhood for this category because it offers commission-free trading and is easy to use. You can search for stocks by company name, and the mobile app is clean and intuitive to use.
• Our pick for building a portfolio. We chose SoFi for this category because it offers both commission-free stocks and a free robo-advisor. That means you can open an active investing account to pick and choose companies you want to invest in, and open a robo-advisor account to help you build a portfolio and manage how much risk you take on.
• Our pick for active traders. We picked Interactive Brokers for this category because it offers advanced tools and low fees for active investors and pros. The simpler IBKR Lite platform is aimed at less-active investors, but all users older than 21 must meet a $20,000 liquid net worth requirement for a cash account.

What's in this guide?

1. NYMX shares summary
2. Compare share dealing platforms
3. Is NYMX stock a buy or sell?
4. Stock performance over time
5. Can I short NYMX shares?
6. Nymox Pharmaceutical Corporation's financials
7. How volatile are NYMX shares?
8. Does Nymox Pharmaceutical Corporation pay a dividend?
9. Other common questions

Nymox Pharmaceutical Corporation share price

Use our graph to track the performance of NYMX stocks over time.

Nymox Pharmaceutical Corporation shares at a glance

• Key figures

Information last updated 2021-02-24.

52-week range	USD$1.66 - USD$4.79
50-day moving average	USD$2.7239
200-day moving average	USD$2.4398
Wall St. target price	USD$10.25
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-0.207

Buy Nymox Pharmaceutical Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Sort by:

Name	Product	Stock trade fee	Asset types	Option trade fee	Annual fee	Signup bonus
Robinhood		$0	Stocks, Options, ETFs, Gold/Commodities	$0	0%	Free stock (chosen randomly with a value anywhere between $2.50 and $200) Sign up using the "go to site" link	Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.	Go to site More Info		loading Fetching your data...
Interactive Brokers		$0	Stocks, Bonds, Options	$0 + $0.65/contract, $1 minimum	0%	N/A	IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.	Go to site More Info		loading Fetching your data...
Tastyworks		$0	Stocks, Options, Cryptocurrency	Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg Futures: $2.50/contract to open, $0 to close	0%	Get 100 shares of stock (worth $1 to $6 a share) Open and fund a new cash or margin account with $2,000+	Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.	Go to site More Info		loading Fetching your data...
Moomoo		$0 for US stocks	Stocks, Options, ETFs	$0		N/A	Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.	Go to site More Info		loading Fetching your data...
TradeStation		$0	Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency	$0 + $0.50/contract		$50 Deposit qualifying assets of $5,000+	A platform built for all kinds of traders and all styles of trading	Go to site More Info		loading Fetching your data...

loading

Compare up to 4 providers

Clear selection

Compare

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Nymox Pharmaceutical Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Nymox Pharmaceutical Corporation by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Shorting Nymox Pharmaceutical Corporation shares

There are currently 3.5 million Nymox Pharmaceutical Corporation shares held short by investors – that's known as Nymox Pharmaceutical Corporation's "short interest". This figure is 4.5% down from 3.6 million last month.

There are a few different ways that this level of interest in shorting Nymox Pharmaceutical Corporation shares can be evaluated.

Nymox Pharmaceutical Corporation's "short interest ratio" (SIR)

Nymox Pharmaceutical Corporation's "short interest ratio" (SIR) is the quantity of Nymox Pharmaceutical Corporation shares currently shorted divided by the average quantity of Nymox Pharmaceutical Corporation shares traded daily (recently around 132010.80773606). Nymox Pharmaceutical Corporation's SIR currently stands at 26.37. In other words for every 100,000 Nymox Pharmaceutical Corporation shares traded daily on the market, roughly 26370 shares are currently held short.

However Nymox Pharmaceutical Corporation's short interest can also be evaluated against the total number of Nymox Pharmaceutical Corporation shares, or, against the total number of tradable Nymox Pharmaceutical Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Nymox Pharmaceutical Corporation's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Nymox Pharmaceutical Corporation shares in existence, roughly 50 shares are currently held short) or 0.078% of the tradable shares (for every 100,000 tradable Nymox Pharmaceutical Corporation shares, roughly 78 shares are currently held short).

A SIR above 20% would generally be considered very high, pointing to a pessimistic outlook for the share price, with a discouraging number of investors currently willing to bet against Nymox Pharmaceutical Corporation.

Find out more about how you can short Nymox Pharmaceutical Corporation stock.

Nymox Pharmaceutical Corporation share price volatility

Over the last 12 months, Nymox Pharmaceutical Corporation's shares have ranged in value from as little as $1.66 up to $4.79. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Nymox Pharmaceutical Corporation's is 1.4861. This would suggest that Nymox Pharmaceutical Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Nymox Pharmaceutical Corporation overview

Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population. Its lead drug candidate is Fexapotide Triflutate (NX-1207) that has completed Phase III clinical trials for the treatment of benign prostatic hyperplasia; and is in Phase II clinical trial for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert and TobacAlert test strips that use urine or saliva to detect use of tobacco products. In addition, it offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimer's disease. The company operates in Canada, the United States, Europe, and internationally. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, Bahamas.

Frequently asked questions

• What percentage of Nymox Pharmaceutical Corporation is owned by insiders or institutions?

  Currently 43.564% of Nymox Pharmaceutical Corporation shares are held by insiders and 6.798% by institutions.

• When does the fiscal year end for Nymox Pharmaceutical Corporation?

  Nymox Pharmaceutical Corporation's fiscal year ends in December.

• Where is Nymox Pharmaceutical Corporation based?

  Nymox Pharmaceutical Corporation's address is: Bay & Deveaux Streets, Nassau, Bahamas

• What is Nymox Pharmaceutical Corporation's ISIN number?

  Nymox Pharmaceutical Corporation's international securities identification number is: BSP733981026

• What is Nymox Pharmaceutical Corporation's CUSIP number?

  Nymox Pharmaceutical Corporation's Committee on Uniform Securities Identification Procedures number is: 670768100